The ASX decide if it’s price sensitive, not Resapp
Ann: ResApp announces FDA 510(k) submission for SleepCheckRx, page-8
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
Add to My Watchlist
What is My Watchlist?